A low dose of digoxin ensures that people with heart failure are hospitalized and die less frequently. This emerges from three studies led by UMCG cardiologists Dirk Jan van Veldhuisen, Kevin Damman, ...

Digoxin, a cardiac glycoside derived from the foxglove plant, has been a mainstay of treatment in systolic heart failure and in rate control for atrial fibrillation. By inhibiting the cardiac ...

NEW ORLEANS, LA—Treating patients with symptomatic rheumatic heart disease (RHD) with digoxin appears to modestly reduce the risk of all-cause mortality or new-onset or worsening heart failure (HF), ...

Patients with rheumatic heart disease who took the heart failure drug digoxin were 18% less likely to die or experience new-onset or worsening heart failure during a two-year follow-up compared with ...

Neck Dissections Based on Sentinel Lymph Node Navigation Versus Elective Neck Dissections in Early Oral Cancers: A Randomized, Multicenter, and Noninferiority Trial Sixty studies, primarily ...

Gemtesa is used to treat urinary urgency, frequency, and incontinence caused by an overactive bladder in adults. This includes certain males with benign prostatic hyperplasia (BPH). Digoxin (Lanoxin) ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Earlier this year, my wife and I welcomed our son ...

Gemtesa (vibegron) is a brand-name medication used for treating overactive bladder (OAB) symptoms like urgency, frequency, and incontinence. It’s also approved for men taking medication for an ...

Patritumab Deruxtecan (HER3-DXd; MK-1022) in Non–Small Cell Lung Cancer After Platinum-Based Chemotherapy and Immunotherapy Many drugs in development continue to follow the historical drug development ...

Heart failure (HF) is the leading cause of hospitalization among older adults. Digoxin has been shown to reduce hospitalization due to worsening HF. However, at the commonly prescribed dose of 0.25 mg ...